Determining individual trajectories of joint space loss: improved statistical methods for monitoring knee osteoarthritis disease progression
Determining individual trajectories of joint space loss: improved statistical methods for monitoring knee osteoarthritis disease progression
Objectives
Knee osteoarthritis (KOA) progression is frequently monitored by calculating the change in knee joint space width (JSW) measurements. Such differences are small and sensitive to measurement error. We aimed to assess the utility of two alternative statistical modelling methods for monitoring KOA.
Material and methods
We used JSW on radiographs from both the control arm of the Strontium Ranelate Efficacy in Knee Osteoarthritis trial (SEKOIA), a 3-year multicentre, double-blind, placebo-controlled phase three trial, and the Osteoarthritis Initiative (OAI), an open-access longitudinal dataset from the USA comprising participants followed over 8 years. Individual estimates of annualised change obtained from frequentist linear mixed effect (LME) and Bayesian hierarchical modelling, were compared with annualised crude change, and the association of these parameters with change in WOMAC pain was examined.
Results
Mean annualised JSW changes were comparable for all estimates, a reduction of around 0.14 mm/y in SEKOIA and 0.08 mm/y in OAI. The standard deviation (SD) of change estimates was lower with LME and Bayesian modelling than crude change (SEKOIA SD = 0.12, 0.12 and 0.21 respectively; OAI SD = 0.08, 0.08 and 0.11 respectively). Estimates from LME and Bayesian modelling were statistically significant predictors of change in pain in SEKOIA (LME P-value = 0.04, Bayes P-value = 0.04), while crude change did not predict change in pain (P-value = 0.10).
Conclusions
Implementation of LME or Bayesian modelling in clinical trials and epidemiological studies, would reduce sample sizes by enabling all study participants to be included in analysis regardless of incomplete follow up, and precision of change estimates would improve. They provide increased power to detect associations with other measures.
Longitudinal, Osteoarthritis, Progression
59-67
Parsons, Camille
9730e5c3-0382-4ed7-8eaa-6932ab09ec15
Judge, Andrew
53ccba98-13f0-4a06-b2ff-59a35616c990
Mayer, Renate
d696ef78-f01b-4e97-a266-0c362eec8089
Bruyere, Olivier
7d127754-d7d6-4328-8f76-212df27727b6
Petit Dop, Florence
0af40637-efb0-4e14-a41f-9a6c9f891916
Chapurlat, Roland
d9410f8c-4e4a-465b-8fb6-67efaadaad4c
Reginster, Jean-Yves
db56b103-184d-46e1-9600-f47f7a09a492
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Inskip, Hazel
5fb4470a-9379-49b2-a533-9da8e61058b7
January 2021
Parsons, Camille
9730e5c3-0382-4ed7-8eaa-6932ab09ec15
Judge, Andrew
53ccba98-13f0-4a06-b2ff-59a35616c990
Mayer, Renate
d696ef78-f01b-4e97-a266-0c362eec8089
Bruyere, Olivier
7d127754-d7d6-4328-8f76-212df27727b6
Petit Dop, Florence
0af40637-efb0-4e14-a41f-9a6c9f891916
Chapurlat, Roland
d9410f8c-4e4a-465b-8fb6-67efaadaad4c
Reginster, Jean-Yves
db56b103-184d-46e1-9600-f47f7a09a492
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Inskip, Hazel
5fb4470a-9379-49b2-a533-9da8e61058b7
Parsons, Camille, Judge, Andrew, Mayer, Renate, Bruyere, Olivier, Petit Dop, Florence, Chapurlat, Roland, Reginster, Jean-Yves, Cooper, Cyrus and Inskip, Hazel
(2021)
Determining individual trajectories of joint space loss: improved statistical methods for monitoring knee osteoarthritis disease progression.
Osteoarthritis and Cartilage, 29 (1), .
(doi:10.1016/j.joca.2020.09.009).
Abstract
Objectives
Knee osteoarthritis (KOA) progression is frequently monitored by calculating the change in knee joint space width (JSW) measurements. Such differences are small and sensitive to measurement error. We aimed to assess the utility of two alternative statistical modelling methods for monitoring KOA.
Material and methods
We used JSW on radiographs from both the control arm of the Strontium Ranelate Efficacy in Knee Osteoarthritis trial (SEKOIA), a 3-year multicentre, double-blind, placebo-controlled phase three trial, and the Osteoarthritis Initiative (OAI), an open-access longitudinal dataset from the USA comprising participants followed over 8 years. Individual estimates of annualised change obtained from frequentist linear mixed effect (LME) and Bayesian hierarchical modelling, were compared with annualised crude change, and the association of these parameters with change in WOMAC pain was examined.
Results
Mean annualised JSW changes were comparable for all estimates, a reduction of around 0.14 mm/y in SEKOIA and 0.08 mm/y in OAI. The standard deviation (SD) of change estimates was lower with LME and Bayesian modelling than crude change (SEKOIA SD = 0.12, 0.12 and 0.21 respectively; OAI SD = 0.08, 0.08 and 0.11 respectively). Estimates from LME and Bayesian modelling were statistically significant predictors of change in pain in SEKOIA (LME P-value = 0.04, Bayes P-value = 0.04), while crude change did not predict change in pain (P-value = 0.10).
Conclusions
Implementation of LME or Bayesian modelling in clinical trials and epidemiological studies, would reduce sample sizes by enabling all study participants to be included in analysis regardless of incomplete follow up, and precision of change estimates would improve. They provide increased power to detect associations with other measures.
Text
OAC10606 Main body (cleaned)
- Accepted Manuscript
Text
OAC10606 Title and abstract page (cleaned)
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 2 September 2020
e-pub ahead of print date: 24 November 2020
Published date: January 2021
Additional Information:
Funding Information:
CP and RM has no conflicts of interest to report. Outside of the submitted work, AJ has recived consultancy fees from Freshfields Bruckhaus Derringer and Anthera Phramaceuticals LTD. Outside the submitted work, OB reports grants from Biophytis, IBSA, MEDA, Servier, and SMB, personal fees from Amgen, Aptissen, Biophytis, IBSA, MEDA, Sanofi, Servier, SMB, and UCB. Outside of the submitted work, J-YR reports consultanty fees from IBSA Genevrier, Mylan, Radius Health, and Pierre Fabre, grants from IBSA Genevrier, Mylan, CNIEL, and Radius Health, and payment for lectures from IBSA Genevrier, Mylan, CNIEL, Dairy Research Council (DRC). HMI salary is provided from the UK Medical Research Council, and outside of the submitted work HMI's institution has received grants from NIHR and the British Heart Foundation. FP-D salary if provided by Servier. Outside of the submitted work, CC reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. Outside of the submitted work, RC reports board membership and consultancy fees from Pfizer.
Funding Information:
We acknowledge the directors and personnel of the 98 investigating centres, all members of the SEKOIA management team (appendix 1) and the study participants. We would also like to express our gratitude to the participants of the OAI. The OAI is a public-private partnership comprised of five contracts ( NO1-AR-2-2258 , NO1-AR-2-2259 , NO1-AR-2-2260 , NO1-AR-2-2261 , NO1-AR-2-2262 ) funded by the National Institutes of Health , a branch of the U.S. Department of Health and Human Services, in four clinical sites and conducted by the OAI study investigators. Work in part supported by a World Universities Network Research Mobility Programme Grant .
Publisher Copyright:
© 2020 Osteoarthritis Research Society International
Keywords:
Longitudinal, Osteoarthritis, Progression
Identifiers
Local EPrints ID: 445514
URI: http://eprints.soton.ac.uk/id/eprint/445514
ISSN: 1063-4584
PURE UUID: a704762e-f79c-4b77-9873-e086b81d3b8c
Catalogue record
Date deposited: 14 Dec 2020 17:31
Last modified: 18 Mar 2024 05:09
Export record
Altmetrics
Contributors
Author:
Camille Parsons
Author:
Andrew Judge
Author:
Renate Mayer
Author:
Olivier Bruyere
Author:
Florence Petit Dop
Author:
Roland Chapurlat
Author:
Jean-Yves Reginster
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics